Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eduards Mamlins

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Reviews in the Neurosciences|July 4, 2020
GABAergic and glutamatergic effects on nigrostriatal and mesolimbic dopamine release in the ratSusanne Nikolaus, Markus Beu, Hans-Jörg Wittsack, et al.
Diagnostics (Basel, Switzerland)|February 25, 2022
Impact of Different Metal Artifact Reduction Techniques on Attenuation Correction of Normal Organs in <sup>18</sup>F-FDG-PET/CTJanna Morawitz, Ole Martin, Johannes Boos, et al.
Neurobiology of Learning and Memory|October 21, 2023
The 5-HT<sub>1A</sub> receptor agonist 8-OH-DPAT modulates motor/exploratory activity, recognition memory and dopamine transporter binding in the dorsal and ventral striatumSusanne Nikolaus, Owen Y Chao, Markus Beu, et al.
EJNMMI Research|March 4, 2022
Is there a diagnostic benefit of late-phase abdomino-pelvic PET/CT after urination as part of whole-body <sup>68</sup> Ga-PSMA-11 PET/CT for restaging patients with biochemical recurrence of prostate cancer after radical prostatectomy?Janna Morawitz, Julian Kirchner, Johannes Hertelendy, et al.
Neuro-Degenerative Diseases|March 16, 2016
FP-CIT- and IBZM-SPECT in Corticobasal Syndrome: Results from a Clinical Follow-Up StudySven Hammesfahr, Christina Antke, Eduards Mamlins, et al.
Seminars in Nuclear Medicine|December 27, 2025
Current status of FAP therapy in solid tumorsSophie C Siegmund, Emil Novruzov, Eduards Mamlins, et al.
Frontiers in Neuroscience|August 30, 2021
Serotonergic Modulation of Nigrostriatal and Mesolimbic Dopamine and Motor/Exploratory Behaviors in the RatSusanne Nikolaus, Hans-Jörg Wittsack, Christina Antke, et al.
Molecular Imaging and Biology|December 8, 2023
The Theranostic Optimization of PSMA-GCK01 Does Not Compromise the Imaging Characteristics of [<sup>99m</sup>Tc]Tc-PSMA-GCK01 Compared to Dedicated Diagnostic [<sup>99m</sup>Tc]Tc-EDDA/HYNIC-iPSMA in Prostate CancerEduards Mamlins, Lara Scharbert, Jens Cardinale, et al.
European Journal of Radiology Open|January 13, 2025
The predictive power of baseline metabolic and volumetric [<sup>18</sup>F]FDG PET parameters with different thresholds for early therapy failure and mortality risk in DLBCL patients undergoing CAR-T-cell therapyEmil Novruzov, Helena A Peters, Kai Jannusch, et al.
Pharmacology, Biochemistry, and Behavior|March 1, 2022
The 5-HT<sub>1A</sub> receptor antagonist WAY-100635 decreases motor/exploratory behaviors and nigrostriatal and mesolimbocortical dopamine D<sub>2/3</sub> receptor binding in adult ratsSusanne Nikolaus, Hans-Jörg Wittsack, Markus Beu, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Reviews in the Neurosciences|July 4, 2020
GABAergic and glutamatergic effects on nigrostriatal and mesolimbic dopamine release in the ratSusanne Nikolaus, Markus Beu, Hans-Jörg Wittsack, et al.
Diagnostics (Basel, Switzerland)|February 25, 2022
Impact of Different Metal Artifact Reduction Techniques on Attenuation Correction of Normal Organs in <sup>18</sup>F-FDG-PET/CTJanna Morawitz, Ole Martin, Johannes Boos, et al.
Neurobiology of Learning and Memory|October 21, 2023
The 5-HT<sub>1A</sub> receptor agonist 8-OH-DPAT modulates motor/exploratory activity, recognition memory and dopamine transporter binding in the dorsal and ventral striatumSusanne Nikolaus, Owen Y Chao, Markus Beu, et al.
EJNMMI Research|March 4, 2022
Is there a diagnostic benefit of late-phase abdomino-pelvic PET/CT after urination as part of whole-body <sup>68</sup> Ga-PSMA-11 PET/CT for restaging patients with biochemical recurrence of prostate cancer after radical prostatectomy?Janna Morawitz, Julian Kirchner, Johannes Hertelendy, et al.
Neuro-Degenerative Diseases|March 16, 2016
FP-CIT- and IBZM-SPECT in Corticobasal Syndrome: Results from a Clinical Follow-Up StudySven Hammesfahr, Christina Antke, Eduards Mamlins, et al.
Seminars in Nuclear Medicine|December 27, 2025
Current status of FAP therapy in solid tumorsSophie C Siegmund, Emil Novruzov, Eduards Mamlins, et al.
Frontiers in Neuroscience|August 30, 2021
Serotonergic Modulation of Nigrostriatal and Mesolimbic Dopamine and Motor/Exploratory Behaviors in the RatSusanne Nikolaus, Hans-Jörg Wittsack, Christina Antke, et al.
Molecular Imaging and Biology|December 8, 2023
The Theranostic Optimization of PSMA-GCK01 Does Not Compromise the Imaging Characteristics of [<sup>99m</sup>Tc]Tc-PSMA-GCK01 Compared to Dedicated Diagnostic [<sup>99m</sup>Tc]Tc-EDDA/HYNIC-iPSMA in Prostate CancerEduards Mamlins, Lara Scharbert, Jens Cardinale, et al.
European Journal of Radiology Open|January 13, 2025
The predictive power of baseline metabolic and volumetric [<sup>18</sup>F]FDG PET parameters with different thresholds for early therapy failure and mortality risk in DLBCL patients undergoing CAR-T-cell therapyEmil Novruzov, Helena A Peters, Kai Jannusch, et al.
Pharmacology, Biochemistry, and Behavior|March 1, 2022
The 5-HT<sub>1A</sub> receptor antagonist WAY-100635 decreases motor/exploratory behaviors and nigrostriatal and mesolimbocortical dopamine D<sub>2/3</sub> receptor binding in adult ratsSusanne Nikolaus, Hans-Jörg Wittsack, Markus Beu, et al.
Pageof 4